Concepedia

Andrea Zaliani

AZ

42

Publications

3K

Citations

22

H-Index

1988

Active since

Affiliations

Fraunhofer Institute for Translational Medicine and Pharmacology(Current)

Merck (Germany)

Goethe University Frankfurt

Italfarmaco (Italy)

Fraunhofer Institute for Algorithms and Scientific Computing

Andrea Zaliani is an author at Fraunhofer Institute for Translational Medicine and Pharmacology specializing in medicine, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

1988–2024

42

Publications

42

On the Art of Compiling and Using 'Drug‐Like' Chemical Fragment Spaces

Jörg Degen, Christof Gerlach, Andrea Zaliani et al. · ChemMedChem · 2008 · 573 citations

, , +16

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

Flavio Leoni, Andrea Zaliani, Giorgio Bertolini et al. · Proceedings of the National Academy of Sciences · 2002 · 500 citations · Full text

, , +18

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle et al. · Stem Cell Reports · 2022 · 233 citations · Full text

ErG:  2D Pharmacophore Descriptions for Scaffold Hopping

Nikolaus Stiefl, Ian A. Watson, Knut Baumann et al. · Journal of Chemical Information and Modeling · 2005 · 179 citations

Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen et al. · ACS Pharmacology & Translational Science · 2021 · 154 citations · Full text

Rows per page

1–5 of 42